Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity.

Kirkland TN, Fierer J.

Virulence. 2018;9(1):1426-1435. doi: 10.1080/21505594.2018.1509667. Review.

2.

Special Issue: Genomic Data in Pathogenic Fungi.

Kirkland TN.

J Fungi (Basel). 2018 Mar 20;4(1). pii: E40. doi: 10.3390/jof4010040.

3.

The Quest for a Vaccine Against Coccidioidomycosis: A Neglected Disease of the Americas.

Kirkland TN.

J Fungi (Basel). 2016 Dec 16;2(4). pii: E34. doi: 10.3390/jof2040034. Review.

4.

Analysis of Transposable Elements in Coccidioides Species.

Kirkland TN, Muszewska A, Stajich JE.

J Fungi (Basel). 2018 Jan 19;4(1). pii: E13. doi: 10.3390/jof4010013.

5.

A few shared up-regulated genes may influence conidia to yeast transformation in dimorphic fungal pathogens.

Kirkland TN.

Med Mycol. 2016 Aug 1;54(6):648-53. doi: 10.1093/mmy/myw019. Epub 2016 Apr 26.

6.

Gene expression in human fungal pathogen Coccidioides immitis changes as arthroconidia differentiate into spherules and mature.

Viriyakosol S, Singhania A, Fierer J, Goldberg J, Kirkland TN, Woelk CH.

BMC Microbiol. 2013 May 28;13:121. doi: 10.1186/1471-2180-13-121.

7.

Factors regulated by interferon gamma and hypoxia-inducible factor 1A contribute to responses that protect mice from Coccidioides immitis infection.

Woelk CH, Zhang JX, Walls L, Viriyakosol S, Singhania A, Kirkland TN, Fierer J.

BMC Microbiol. 2012 Sep 24;12:218. doi: 10.1186/1471-2180-12-218.

8.

The role of reactive oxygen intermediates in experimental coccidioidomycois in mice.

Margolis DA, Viriyakosol S, Fierer J, Kirkland TN.

BMC Microbiol. 2011 Apr 11;11:71. doi: 10.1186/1471-2180-11-71.

9.

Population genomic sequencing of Coccidioides fungi reveals recent hybridization and transposon control.

Neafsey DE, Barker BM, Sharpton TJ, Stajich JE, Park DJ, Whiston E, Hung CY, McMahan C, White J, Sykes S, Heiman D, Young S, Zeng Q, Abouelleil A, Aftuck L, Bessette D, Brown A, FitzGerald M, Lui A, Macdonald JP, Priest M, Orbach MJ, Galgiani JN, Kirkland TN, Cole GT, Birren BW, Henn MR, Taylor JW, Rounsley SD.

Genome Res. 2010 Jul;20(7):938-46. doi: 10.1101/gr.103911.109. Epub 2010 Jun 1.

10.

Arenimycin, an antibiotic effective against rifampin- and methicillin-resistant Staphylococcus aureus from the marine actinomycete Salinispora arenicola.

Asolkar RN, Kirkland TN, Jensen PR, Fenical W.

J Antibiot (Tokyo). 2010 Jan;63(1):37-9. doi: 10.1038/ja.2009.114. Epub 2009 Nov 20. No abstract available.

11.

Comparative genomic analyses of the human fungal pathogens Coccidioides and their relatives.

Sharpton TJ, Stajich JE, Rounsley SD, Gardner MJ, Wortman JR, Jordar VS, Maiti R, Kodira CD, Neafsey DE, Zeng Q, Hung CY, McMahan C, Muszewska A, Grynberg M, Mandel MA, Kellner EM, Barker BM, Galgiani JN, Orbach MJ, Kirkland TN, Cole GT, Henn MR, Birren BW, Taylor JW.

Genome Res. 2009 Oct;19(10):1722-31. doi: 10.1101/gr.087551.108. Epub 2009 Aug 28.

12.

Characterization of monoclonal antibodies to human soluble MD-2 protein.

Viriyakosol S, McCray PB, Ashbaugh ME, Chu J, Jia HP, Weiss J, Kirkland TN.

Hybridoma (Larchmt). 2006 Dec;25(6):349-57.

PMID:
17203997
13.

Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein.

Shubitz LF, Yu JJ, Hung CY, Kirkland TN, Peng T, Perrill R, Simons J, Xue J, Herr RA, Cole GT, Galgiani JN.

Vaccine. 2006 Jul 26;24(31-32):5904-11. Epub 2006 Apr 18.

PMID:
16759762
14.

Mutational analysis of membrane and soluble forms of human MD-2.

Viriyakosol S, Tobias PS, Kirkland TN.

J Biol Chem. 2006 Apr 28;281(17):11955-64. Epub 2006 Feb 8.

15.
16.

Characterization of a serodiagnostic complement fixation antigen of Coccidioides posadasii expressed in the nonpathogenic Fungus Uncinocarpus reesii.

Yu JJ, Kirkland TN, Hall LK, Wopschall J, Smith RC, Hung CY, Chen X, Tarcha E, Thomas PW, Cole GT.

J Clin Microbiol. 2005 Nov;43(11):5462-9.

17.

Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.

Kirkland TN, Raz E, Datta SK.

Vaccine. 2006 Jan 23;24(4):495-500. Epub 2005 Aug 15.

PMID:
16181709
18.

Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1.

Viriyakosol S, Fierer J, Brown GD, Kirkland TN.

Infect Immun. 2005 Mar;73(3):1553-60.

19.

Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS.

Thompson PA, Tobias PS, Viriyakosol S, Kirkland TN, Kitchens RL.

J Biol Chem. 2003 Aug 1;278(31):28367-71. Epub 2003 May 15.

20.

Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells.

Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN, Witztum JL.

J Biol Chem. 2003 Jan 17;278(3):1561-8. Epub 2002 Nov 6.

21.

MD-2 binds to bacterial lipopolysaccharide.

Viriyakosol S, Tobias PS, Kitchens RL, Kirkland TN.

J Biol Chem. 2001 Oct 12;276(41):38044-51. Epub 2001 Aug 10.

22.

The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections.

Polonelli L, Casadevall A, Han Y, Bernardis F, Kirkland TN, Matthews RC, Adriani D, Boccanera M, Burnie JP, Cassone A, Conti S, Cutler JE, Frazzi R, Gregory C, Hodgetts S, Illidge C, Magliani W, Rigg G, Santoni G.

Med Mycol. 2000;38 Suppl 1:281-92. Review.

PMID:
11204156
23.
24.
25.

Structure-function analysis of CD14 as a soluble receptor for lipopolysaccharide.

Viriyakosol S, Mathison JC, Tobias PS, Kirkland TN.

J Biol Chem. 2000 Feb 4;275(5):3144-9.

26.
27.

Importance of interleukin-10 in genetic susceptibility of mice to Coccidioides immitis.

Fierer J, Walls L, Eckmann L, Yamamoto T, Kirkland TN.

Infect Immun. 1998 Sep;66(9):4397-402.

28.

Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice.

Kirkland TN, Finley F, Orsborn KI, Galgiani JN.

Infect Immun. 1998 Aug;66(8):3519-22.

29.

Structure-function analysis of soluble and membrane-bound CD14.

Kirkland TN, Viriyakosol S.

Prog Clin Biol Res. 1998;397:79-87. Review. No abstract available.

PMID:
9575549
30.

Immunogenicity of a 48-kilodalton recombinant T-cell-reactive protein of Coccidioides immitis.

Kirkland TN, Thomas PW, Finley F, Cole GT.

Infect Immun. 1998 Feb;66(2):424-31.

31.

Isolation and characterization of the urease gene (URE) from the pathogenic fungus Coccidioides immitis.

Yu JJ, Smithson SL, Thomas PW, Kirkland TN, Cole GT.

Gene. 1997 Oct 1;198(1-2):387-91.

PMID:
9370306
32.

The hsp60 gene of the human pathogenic fungus Coccidioides immitis encodes a T-cell reactive protein.

Thomas PW, Wyckoff EE, Pishko EJ, Yu JJ, Kirkland TN, Cole GT.

Gene. 1997 Oct 15;199(1-2):83-91.

PMID:
9358043
33.

CD14 is a cell-activating receptor for bacterial peptidoglycan.

Gupta D, Kirkland TN, Viriyakosol S, Dziarski R.

J Biol Chem. 1996 Sep 20;271(38):23310-6.

34.

Coccidioidomycosis: a reemerging infectious disease.

Kirkland TN, Fierer J.

Emerg Infect Dis. 1996 Jul-Sep;2(3):192-9. Review.

35.
36.
38.

A region of human CD14 required for lipopolysaccharide binding.

Viriyakosol S, Kirkland TN.

J Biol Chem. 1995 Jan 6;270(1):361-8.

39.

Analysis of lipopolysaccharide binding by CD14.

Kirkland TN, Finley F, Leturcq D, Moriarty A, Lee JD, Ulevitch RJ, Tobias PS.

J Biol Chem. 1993 Nov 25;268(33):24818-23.

40.

Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin.

Lee JD, Kravchenko V, Kirkland TN, Han J, Mackman N, Moriarty A, Leturcq D, Tobias PS, Ulevitch RJ.

Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9930-4.

41.

Identification of antigens of Coccidioides immitis which stimulated immune T lymphocytes.

Cole GT, Kirkland TN.

Arch Med Res. 1993 Autumn;24(3):281-91.

PMID:
8298279
42.
43.

Coccidioides immitis fractions which are antigenic for immune T lymphocytes.

Kirkland TN, Zhu SW, Kruse D, Hsu LL, Seshan KR, Cole GT.

Infect Immun. 1991 Nov;59(11):3952-61.

44.

Lipopolysaccharidelike immunological properties of cell wall glycoproteins isolated from Cytophaga johnsonae.

de Jong DM, Pate JL, Kirkland TN, Taylor CE, Baker PJ, Takayama K.

Infect Immun. 1991 Aug;59(8):2631-7.

47.

Physicochemical properties of the lipopolysaccharide unit that activates B lymphocytes.

Takayama K, Din ZZ, Mukerjee P, Cooke PH, Kirkland TN.

J Biol Chem. 1990 Aug 15;265(23):14023-9.

48.

Identification of lipopolysaccharide-binding proteins in 70Z/3 cells by photoaffinity cross-linking.

Kirkland TN, Virca GD, Kuus-Reichel T, Multer FK, Kim SY, Ulevitch RJ, Tobias PS.

J Biol Chem. 1990 Jun 5;265(16):9520-5.

49.
50.

Inhibition of lipopolysaccharide activation of 7OZ/3 cells by anti-lipopolysaccharide antibodies.

Kirkland TN, Ziegler EJ, Tobias P, Ward DC, Michalek SM, McGhee JR, Macher I, Urayama K, Appelmelk BJ.

J Immunol. 1988 Nov 1;141(9):3208-13.

PMID:
3262686

Supplemental Content

Loading ...
Support Center